Company Management

Sperogenix Therapeutics 曙方医药

Pharmaceutical Manufacturing 京, Cn 15 employees

Employees: 15
Contacts: 2
Emails: 2
Phones: 1

sperogenix.com LinkedIn Crunchbase

Sperogenix Therapeutics 曙方医药 Overview

Headquarters: 京, Cn
Website: sperogenix.com
Industry: Pharmaceutical Manufacturing
Employees: 15
Founded: 2019
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

罕见病和孤儿药制药新药研发互联网医疗

About Sperogenix Therapeutics 曙方医药

Sperogenix Therapeutics is a platform company dedicated to developing and commercializing rare disease therapeutics in China with focus on mid-to-late clinical stage and commercial stage products. With prioritized therapeutic areas, such as Pulmonary Vascular Disorders, Neurological Disorders, Inherited Metabolic Diseases, and Non-oncology Hematology Disorders, Sperogenix is dedicated to establishing an innovative commercial model tailored to the China rare disease field, in order to provide affordable and reliable products and services to Chinese physicians and patients. Sperogenix was founded in 2019 and is backed by biopharma industry blue chip investors including Lilly Asia Ventures (LAV) and Morningside Venture in the A-round financing.

Sperogenix Therapeutics 曙方医药 Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Sperogenix Therapeutics 曙方医药 Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tristan Xia	Bd Director		View
Liang Sha	Clinical Development	Pudong, Shanghai, China	Email
Kelly Tang	Hrd，tmod		View
Hanlan Liu, Ph.d., Mba	Biotech Executive - Researcher	Cambridge, Massachusetts, United States	Email Phone